Successful therapy of refractory Hailey–Hailey disease with oral alitretinoin

Authors


  • Funding sources: none.
  • Conflicts of interest: T.R. was a principal investigator, speaker and consultant for Basilea Pharmaceutica.

No abstract is available for this article.

Ancillary